Skip to main content
Livermore
Livermore
ZHEN

TD Private Client Wealth LLC

SEC CIK
0001551017
Latest filing
Aug 4, 2026

TAK holding history

Takeda Pharmaceutical Co Ltd in every 13F filed by TD Private Client Wealth LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TAK overviewAll 13F holders of TAKFull Q2 2026 holdings

Shares (Q2 2026)
22,050
Value
$353.5K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of TAK by TD Private Client Wealth LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202622,050$353.5K<0.1%−1,875−7.8%ReducedHolders
Q1 202623,925$443.1K<0.1%+14,101+143.5%AddedHolders
Q4 20259,824$153.2K<0.1%+9,571+3,783.0%AddedHolders
Q3 2025253$3.70K<0.1%00.0%UnchangedHolders
Q2 2025253$3.91K<0.1%−64−20.2%ReducedHolders
Q1 2025317$4.71K<0.1%+79+33.2%AddedHolders
Q4 2024238$3.15K<0.1%00.0%UnchangedHolders
Q3 2024238$3.38K<0.1%00.0%UnchangedHolders
Q2 2024238$3.08K<0.1%+123+107.0%AddedHolders
Q1 2024115$1.60K<0.1%00.0%UnchangedHolders
Q4 2023115$1.64K<0.1%00.0%UnchangedHolders
Q3 2023115$1.78K<0.1%00.0%UnchangedHolders
Q2 2023115$1.81K<0.1%−87−43.1%ReducedHolders
Q1 2023202$3.33K<0.1%−934−82.2%ReducedHolders
Q4 20221,136$17.7K<0.1%+1,136NewHolders
Q2 20220$00.0%−472−100.0%Sold outHolders
Q1 2022472$6.76K<0.1%00.0%UnchangedHolders
Q4 2021472$6.43K<0.1%−18,893−97.6%ReducedHolders
Q3 202119,365$317.2K<0.1%−6,765−25.9%ReducedHolders
Q2 202126,130$439.8K<0.1%−615−2.3%ReducedHolders
Q1 202126,745$488.4K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.